Alliance Life Sciences Announces Strategic Leadership Changes to Drive Growth

Share Article

Alliance Life Sciences, a leading global life sciences consulting, data and technology provider, is pleased to announce strategic leadership changes to drive growth and expand our footprint in the pharmaceutical, distributor and medical devices industries.

News Image

Alliance Life Sciences

These leadership changes and investments that will allow us to provide great value and impact to our customers as a trusted partner, allowing us to meet the rapidly growing needs of Life Sciences firms to optimize price and revenue manage

Alliance Life Sciences, a leading global life sciences consulting, data and technology provider, is pleased to announce strategic leadership changes to drive growth and expand our footprint in the pharmaceutical, distributor and medical devices industries.

Emmanuel Doe, President & Chief Operating Officer will assume the role of Chief Executive Officer. Emmanuel, will drive the company’s strategic growth initiatives and support the organization’s expanded offerings and capabilities in the ever-changing life sciences industry. He comes to Alliance Life Sciences as a Divisional President of Interactive Data, where he focused on building best in class teams, technology and solutions to transform its software, data and service business.

With a strong focus on the European marketplace, Alan Crowther will be assuming the role of President, Global Markets where he will be dedicated to expanding the global pricing data solutions and pricing lifecycle management software. Over the past four years, Alan has been instrumental in launching and expanding the global pricing business. In his new role, he will direct capital investments in the global pricing business and drive innovative offerings to better serve our global customers. Alan will continue to serve on the board of directors and contribute to the strategic direction of the firm.

As part of the global services a newly formed role of Chief Client Officer has been filled by Bob Pietrobono. This new role increases the capability to strengthen client relationships and build partnerships across the industry. Bob’s experience serving Life Sciences clients as a partner in the consulting firms of Deloitte and Ernst and Young in addition to his Global Account Executive for Model N, uniquely positions him for the role.

“We are excited by our leadership changes and capital investments that positions us to provide greater value and impact to our customers as trusted advisors. This offers us the ability to better serve our clients and meet the rapidly growing needs of Life Sciences organizations,” said Emmanuel Doe, Chief Executive Officer.

About Alliance Life Sciences        
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. With over fifteen years of dedicated life sciences experience, our worldwide team of experts provides insights and solves problems in Contracting, Pricing, Reimbursement, and Commercial Operations. We serve top pharmaceutical manufacturers, mid-market life sciences companies, and multiple medical device and diagnostic firms. Contact: 866.581.4850 or http://www.alscg.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sophie Ferronato
Alliance Life Sciences
since: 07/2010
Like >
Visit website

Media